Back to search

Article

Survival and prognostic factors in non-small cell lung cancer patients with brain metastases limited access to systemic therapy

2022-12-20

Abstract excerpt

<h4>Background: </h4> Survival after diagnosis of brain metastases in non-small cell lung cancer (NSCLC) patients was dismal even after local therapy (surgery or brain irradiation), partly because of the systemic burden. Paucities of medical oncologists and molecular testing plus disparities in health care coverage resulted in limited access to systemic chemotherapy, let alone targeted drug or immunotherapy, for b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f3c590b6-985b-5d5e-8b0f-2c585f887485
DOI
10.21203/rs.3.rs-2324452/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Survival and prognostic factors in non-small cell lung cancer patients with brain metastases limited access to systemic therapyDOI 10.21203/rs.3.rs-2324452/v1
Select a neighboring publication to make it the new centre.